Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial-Reference-Cited by-同舟云学术

Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial

Published:2023-06 Issue:6 Volume:83 Page:571-579
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Roy Soumyajit,Sun Yilun,Morgan Scott C.,Wallis Christopher J.D.,King Kevin,Zhou Yu M.,D'souza Leah A.,Azem Omar,Cueto-Marquez Adrianna E.,Camden Nathaniel B.,Spratt Daniel E.,Kishan Amar U.,Saad Fred,Malone Shawn

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Prostate cancer, version 2.2019;Mohler;J Natl Compre Cancer Netw,2019

2. Mechanistic insights into molecular targeting and combined modality therapy for aggressive, localized prostate cancer;Dal Pra;Front Oncol,2016

3. Combination of androgen deprivation therapy with radical local therapy versus androgen deprivation therapy alone for newly diagnosed oligometastatic prostate cancer: a phase II randomized controlled trial;Dai;Eur Urol Oncol,2022

4. Prostate radiotherapy for metastatic hormone-sensitive prostate cancer: a STOPCAP systematic review and meta-analysis;Burdett;Eur Urol,2019

5. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial;Parker;Lancet,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN Study;European Urology;2024-04

2. Reply to Xiao Li, Zicheng Xu, and Feng Qi’s Letter to the Editor re: Soumyajit Roy, Yilun Sun, Scott C. Morgan, et al. Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial. Eur Urol 2023;83:571–9;European Urology;2024-01

3. Re: Soumyajit Roy, Yilun Sun, Scott C. Morgan, et al. Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial. Eur Urol 2023;83:571–9;European Urology;2024-01